Related Experiment Video
Updated: Apr 18, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Role of CaMKII in cardiac arrhythmias
Thomas J Hund1, Peter J Mohler2
1The Dorothy M. Davis Heart & Lung Research Institute, OH; Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH; Department of Biomedical Engineering, The Ohio State University College of Engineering, Columbus, OH.
Abstract:
Protein phosphorylation is a central mechanism in vertebrates for the regulation of signaling. With regard to the cardiovascular system, phosphorylation of myocyte targets is critical for the regulation of excitation contraction coupling, metabolism, intracellular calcium regulation, mitochondrial activity, transcriptional regulation, and cytoskeletal dynamics. In fact, pathways that tune protein kinase signaling have been a mainstay for cardiovascular therapies for the past 60 years. The calcium/calmodulin-dependent protein kinase II (CaMKII) is a multifunctional serine/threonine kinase with numerous roles in human physiology. Dysfunction in CaMKII-based signaling has been linked with a host of cardiovascular phenotypes including heart failure and arrhythmia, and CaMKII levels are elevated in human and animal disease models of heart disease. While nearly a decade has been invested in targeting CaMKII for the treatment of heart failure and arrhythmia phenotypes, to date, approaches to target the molecule for antiarrhythmic benefit have been unsuccessful for reasons that are still not entirely clear, although (1) lack of compound specificity and (2) the multitude of downstream targets are likely contributing factors. This review will provide an update on current pathways regulated by CaMKII with the goal of illustrating potential upstream regulatory mechanisms and downstream targets that may be modulated for the prevention of cardiac electrical defects. While the review will cover multiple aspects of CaMKII dysfunction in cardiovascular disease, we have given special attention to the potential of CaMKII-associated late Na(+) current as a novel therapeutic target for cardiac arrhythmia.
Insights
Calcium/calmodulin-dependent protein kinase II (CaMKII) is crucial for cardiovascular signaling. Targeting CaMKII, particularly its association with late sodium current, may offer new strategies for preventing cardiac arrhythmias.
Area of Science:
- Cardiovascular Physiology
- Molecular Biology
- Biochemistry
Background:
- Protein phosphorylation regulates vital cardiovascular functions, including excitation-contraction coupling and metabolism.
- Calcium/calmodulin-dependent protein kinase II (CaMKII) plays a critical role in cardiac physiology, with its dysfunction linked to heart failure and arrhythmia.
- Despite extensive research, targeting CaMKII for antiarrhythmic therapies has faced challenges due to specificity and numerous downstream targets.
Purpose of the Study:
- To review current CaMKII-regulated pathways in the cardiovascular system.
- To identify potential upstream regulatory mechanisms and downstream targets for modulating CaMKII signaling.
- To explore the potential of CaMKII-associated late Na(+) current as a novel therapeutic target for cardiac arrhythmia.
Main Methods:
- Literature review of CaMKII signaling in cardiovascular disease.
- Analysis of CaMKII's role in excitation-contraction coupling, metabolism, and electrical activity.
- Investigation of CaMKII's association with ion channel function, particularly the late Na(+) current.
Main Results:
- CaMKII is implicated in multiple cardiac processes, and its dysregulation contributes to cardiovascular pathologies.
- Previous attempts to target CaMKII for antiarrhythmic effects have been hindered by lack of specificity and complexity of its targets.
- The CaMKII-associated late Na(+) current presents a promising, specific target for novel antiarrhythmic strategies.
Conclusions:
- CaMKII is a key regulator of cardiovascular function, and its aberrant activity contributes to disease.
- Understanding CaMKII's upstream and downstream effectors is crucial for developing effective cardiovascular therapies.
- Targeting the CaMKII-associated late Na(+) current offers a potential new avenue for treating cardiac arrhythmias.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Electrophysiology of Normal Cardiac Rhythm
G-Protein Gated Ion Channels
Sensory...
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

